Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC) Meeting Abstract


Authors: Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
Abstract Title: Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601587
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.4573
Notes: Meeting Abstract: 4573 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer
  2. Martin Henner Voss
    288 Voss
  3. Yingbei Chen
    398 Chen
  4. Shugaku Takeda
    18 Takeda
  5. James J Hsieh
    125 Hsieh
  6. Han Liu
    13 Liu
  7. Michael Forman Berger
    766 Berger
  8. Angela Rose Brannon
    99 Brannon
  9. Can Gia Pham
    8 Pham
  10. Abraham Ari Hakimi
    324 Hakimi
  11. Sasinya Neka Scott
    70 Scott